CSL’s Melbourne Broadmeadows facility had a positive COVID-19 case
One of the CSL production facilities producing the Astra Zeneca Covid vaccine, Vaxzevria, has had a positive COVID-19 case of its own, the company has confirmed.
CSL said in a statement there had been a single positive COVID-19 case at its Broadmeadows manufacturing facility last week.
Melbourne 3AW radio broadcaster Neil Mitchell first broadcast news of the case on Monday, following what he described as a “red hot tip”.
“Now, I’m told it’s not compromising their operations, thankfully, but it is a good reminder that anybody can be affected by this,” he said on air.
According to CSL; “All employees and contractors who were present at the same time as the confirmed case have been tracked and traced, and close contacts isolated.” the statement said.
“We are pleased that there have been no further positive cases identified,” it said.
According to the company the facility, continued to operate as usual with no interruption to any of its production following a deep clean which was undertaken at the facility.
Its Parkville site, which completes production of the AstraZeneca vaccine, was similarly unaffected.
The CSL plants are producing over 50 million of the Oxford-AstraZeneca COVID-19 vaccine.
In concluding, CSL took the opportunity to “strongly encourage all of our people, their families and every Australian to get vaccinated against COVID-19”.
“As a science-based company which includes the world’s second largest provider of influenza vaccines, we have a comprehensive understanding and appreciation for the public health value that vaccines provide,” it said.
Click here to see the CSL statement